Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers
The outcome of Mycobacterium tuberculosis (Mtb) infection ranges from a complete pathogen clearance through asymptomatic latent infection (LTBI) to active tuberculosis (TB) disease. It is now understood that LTBI and active TB represent a continuous spectrum of states with different degrees of patho...
Saved in:
Main Authors: | I. V. Lyadova, A. V. Panteleev |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2015/854507 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Alteration and Clinical Significance of Th22/Th17/Th1 Cells in Patients with Chronic Myeloid Leukemia
by: Ping Chen, et al.
Published: (2015-01-01) -
Circulating Th1, Th2, Th17, Treg, and PD-1 Levels in Patients with Brucellosis
by: Rongjiong Zheng, et al.
Published: (2019-01-01) -
Circulating Th17, Th22, and Th1 Cells Are Elevated in the Guillain-Barré Syndrome and Downregulated by IVIg Treatments
by: Shujuan Li, et al.
Published: (2014-01-01) -
The Role of Th17 Cells and IL-17 in Th2 Immune Responses of Allergic Conjunctivitis
by: Xiang-Tian Meng, et al.
Published: (2020-01-01) -
Th17 Cells in Immunity and Autoimmunity
by: Simone Kennedy Bedoya, et al.
Published: (2013-01-01)